Clinical Trial: A Real-world Study of the Efficacy and Safety of PD-1 Inhibitors Combined With Chemoradiotherapy in Lung Metastatic Nasopharyngeal Carcinoma

U.S., July 15 -- ClinicalTrials.gov registry received information related to the study (NCT07062484) titled 'A Real-world Study of the Efficacy and Safety of PD-1 Inhibitors Combined With Chemoradiotherapy in Lung Metastatic Nasopharyngeal Carcinoma' on July 02.

Brief Summary: This study is a retrospective real-world study. In this study, we plan to collect the clinical data of lung metastatic nasopharyngeal carcinoma patients who received PD-1 inhibitors and chemotherapy combined with or without radiotherapy.

Study Start Date: July, 2025

Study Type: INTERVENTIONAL

Condition: Lung Metastatic Nasopharyngeal Carcinoma

Intervention: DRUG: Control: gemcitabine, cisplatin, tirelizumab

PD-1 inhibitors combined with chemotherapy

DRUG: Exp...